Matthew Autterson And His Rise To The Top

Matthew Autterson is one of the not so many individuals who are truly conversant with matters related to management in the financial services industry. So seasoned is he that for not less than twenty-five years, he has been involved in the management and running of among them, the biggest financial services company that had attained state-chartered credentials when he was its president.

Matthew went and graduated from university in the year 1980 with a Bachelor of Arts degree in Finances. Around the same time, he was graduating, he was lucky to have successfully undergone the Graduate Tax Program that was being offered by the University of Denver at the time. Coupled with both qualifications at the time, he was more than ready to face the corporate professional world with confidence.

He started working at First Trust Corporation and after two years of diligent service, he left and became part of a group that wanted to start a Colorado based state-chartered financial services firm that would have its subsidiary based in New York. The dream was successful and within a short duration of time, Resources Trust Company opened its doors.

At the time, Resources Trust Company was a subsidiary of Integrated Resources Inc. After being involved in the company at top management positions, he was finally appointed the chairman in the year 1986. He worked steadily and made the company profit a great deal within a short duration of time. The company was growing in leaps and bounds and buyout propositions were coming from left, right and center.

After three years being President, the company was bought out by Broad Inc. together with all other assets that were owned by its mother company. After a short period of time, Broad Inc. was also bought out by SunAmerica Inc. which would later on be acquired by AIG. While still under his leadership, Resources Trust was bought by AIG in the year 2001. Get Additional Information Here.

Matthew has throughout his career proven that he is no doubt a reliable professional when it comes to steering companies in the right direction. Before the final sale was made, the company was among the best state-chartered FDIC-insured companies in the country. It had won the confidence of many investors owing to its brilliant success stories.

Matthew is currently the Chairman of Falci Adaptive. He also sits in many other companies’ boards in different capacities. Matthew Autterson is a committed philanthropist who supports different causes with his time and money.


View Source:

Scott Rocklage’s Role in Treating DM 1

Expansion Therapeutics is a company that is highly dedicated to the development of drugs that are used to treat RNA-mediated diseases. The group has been sponsored by a few companies in its quest to develop a drug for myotonic dystrophy type 1. These sponsor companies include Sanofi Ventures, Novartis Venture Fund, Kleiner Perkins, 5 AM Ventures, Alexandria Venture Investment, and RA Capital Management. The Managing Partner of 5 AM Ventures, Dr. Scott Rocklage is also the Chairman of the Board of Directors of Expansion Therapeutics. Learn more:


Myotonic dystrophy type 1 is also called DM 1. The disease is the leading cause of muscular dystrophy in adults. The signs and symptoms of the disease project themselves once RNA reaches toxic levels. RNAs are molecules that develop from DNA to form proteins. Production of some types of RNAs may reach toxic levels and lead to the formation of myotonic dystrophy type 1. When the disease is at its full-blown stage, body systems such as the gastrointestinal system, the respiratory system, and the central nervous system start to fail or slow down. Major organs such as the heart and muscles may begin to become defective and thus cause paralysis of other metabolic operations of the body.


Expansion Therapeutics mainly deals with the development of drugs for diseases that are called expansion repeat disorders. These are complications that are hereditary and have a slow response to the current medications on the market. The company conducts its developments in the laboratories of Dr. Matthew D. Disney. Dr. Scott Rocklage who is the founding investor of Expansion Therapeutics said in a press conference that the leading researcher in the drug development exercise is Dr. Disney.


Dr. Scott Rocklage has been the Managing Partner of 5 AM Ventures for many years. Dr. Rocklage is a graduate of some of the most reputable learning institutions in the country. He is a holder of Bachelor of Science degree in Chemistry from the University of California. He also has a Ph.D. in Chemistry from Massachusetts Institute of Technology (MIT). During his time at MIT, Mr. Scott Rocklage did his research in Dr. Richard Shrock’s laboratory. Dr. Shrock was the winner of the prestigious Nobel Prize in Chemistry in 2005.


He joined 5 AM Ventures in 2003 as a Venture Partner. In 2004, Dr. Rocklage was made the Managing Partner of the institution. He is highly experienced in the healthcare management. He was once the CEO of Cubist Pharmaceuticals. Dr. Rocklage was also the CEO and President of Nycomed Salutar at some point.